Clinical Study

Visual and Anatomical Outcomes of Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration

Figure 1

Visual results over time after aflibercept conversion. BCVA: best-corrected visual acuity; ETDRS: early treatment diabetic retinopathy study.
273754.fig.001